Admin Core
管理核心
基本信息
- 批准号:10598770
- 负责人:
- 金额:$ 28.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS related cancerAddressAfricaAfrica South of the SaharaAfricanBiological MarkersCancer CenterCaringChronic DiseaseClimateClinicalCollaborationsCommunicationComplexCountryDetectionDevelopmentDiagnosisDiagnosticDiseaseEnsureEnvironmentGoalsGroup MeetingsHIVHIV-1Health SciencesHospitalsHuman Herpesvirus 8Immune responseImmunologicsImmunosuppressionIndividualInformation DisseminationInfrastructureInstitutionInternationalKaposi SarcomaLeadershipLocationLouisianaMalignant NeoplasmsMissionOceansOutcomeOutcomes ResearchPathogenesisPersonsPilot ProjectsPoliciesPreventionProcessResearchResearch ActivityResearch InfrastructureResearch Project GrantsResource SharingResourcesSeriesTanzaniaTeaching HospitalsTechnologyTissuesTrainingUnited StatesUnited States National Institutes of HealthUniversitiesViralViral reservoirVirus LatencyWorkZambiaanticancer researchantiretroviral therapycareer developmentdata disseminationdata integrationdata managementdata sharingdesignexperienceimprovedmeetingsmetabolomicspreventprogramssuccesssynergism
项目摘要
A multi-institutional, international, and integrated endeavor, the “KS in the Era of ART in Africa Program
(KEAAP)” will leverage the research and training expertise of collaborating institutions from the U.S. and two
African countries: the Louisiana State University Health Sciences Center-New Orleans (LSUHSC-NO), the
Cancer Diseases Hospital (CDH) and the University Teaching Hospitals (UTH) of Zambia, and the Ocean
Road Cancer Institute (ORCI) in Dar es Salaam, Tanzania to form an HIV-Associated Malignancy Research
Center (HAMRC) that focuses on the research gaps of the Kaposi sarcoma (KS) disease. Building on the
success of their previous collaborations, these institutions will synergize their efforts under one overarching
research theme that focuses on the KS disease spectrum, from detection, to care and outcomes, to
deciphering KS pathogenesis and immune response. The immediate goal is to 1) implement a program to
better integrate KS diagnostic, clinical and research activities within the HIV-1 care and treatment networks in
both countries; 2) define stage- and treatment-associated immunologic and metabolomics biomarkers across
the spectrum of KS disease presentation; and 3) define the magnitude and breadth of Kaposi sarcoma
herpesvirus (KSHV) latent viral reservoirs in tissues of KSHV infected people living with HIV, so that these
reservoirs could be targeted for prevention of viral reactivation to prevent KS. To achieve this goal and promote
synergy and coordination across partnering institutions, KEAAP will establish an Administrative Core, based at
LSUHSC-NO with satellite locations at UTH/CDH, and ORCI, that will provide the administrative support
needed to ensure that KEAAP’s three research projects, Shared Resource Core (Data Management and
Integration Core), and Career Development Core can accomplish their individual and collective goals while
functioning in an integrated and coordinated manner. The Administrative Core will pursue four specific aims.
1) Provide the administrative expertise and resources necessary to support the consortium’s research projects
and cores and the pilot projects to accomplish their goals and specific aims. 2) Implement a consortium-wide
series of operational processes designed to create a collaborative research environment, promote data sharing
and dissemination of results, and build capacity for increased self-sufficiency at cancer research institutions in
Tanzania and Zambia. 3) Provide communications infrastructure to engage key stakeholders, to promote the
consortium, and disseminate information and research outcomes that will inform healthy policy changes locally,
and globally. The organization of the Administrative Core is designed to be responsive, inclusive, and robust –
attributes that are essential to address the broad mission and complex relationships within KEAAP, among
collaborating institutions, and with NIH. The core will focus on meeting the needs of the collaborators in a
climate of rapidly changing scientific and technological advances in order to promote a sustainable consortium
with vibrant research programs that work toward the reduction of cancer in sub-Saharan Africa.
“非洲艺术时代的 KS 计划”是一项多机构、国际和综合性的努力
(KEAAP)”将利用美国和两个合作机构的研究和培训专业知识
非洲国家:路易斯安那州立大学健康科学中心-新奥尔良 (LSUHSC-NO)、
赞比亚癌症疾病医院 (CDH) 和大学教学医院 (UTH) 以及海洋
坦桑尼亚达累斯萨拉姆道路癌症研究所 (ORCI) 将组建艾滋病毒相关恶性肿瘤研究中心
中心(HAMRC)专注于卡波西肉瘤(KS)疾病的研究空白。
继之前的合作取得成功后,这些机构将在一个总体框架下协同努力
研究主题侧重于 KS 疾病谱,从检测到护理和结果,再到
破译 KS 发病机制和免疫反应 近期目标是 1) 实施一项计划
更好地将 KS 诊断、临床和研究活动纳入 HIV-1 护理和治疗网络
两国;2) 定义与阶段和治疗相关的免疫学和代谢组学生物标志物
KS 疾病的表现范围;3) 定义卡波西肉瘤的大小和范围
疱疹病毒 (KSHV) 潜伏在 KSHV 组织中的病毒库感染了 HIV 感染者,因此这些
可以针对病毒储存库进行针对性预防,以预防 KS 的发生并促进这一目标。
合作机构之间的协同和协调,KEAAP 将建立一个行政核心,总部设在
LSUHSC-NO 在 UTH/CDH 和 ORCI 设有卫星位置,将提供行政支持
需要确保 KEAAP 的三个研究项目:共享资源核心(数据管理和
整合核心)和职业发展核心可以实现他们的个人和集体目标,同时
行政核心以综合协调的方式运作,将实现四个具体目标。
1) 提供支持联盟研究项目所需的管理专业知识和资源
以及核心和试点项目,以实现其目标和具体目标 2) 在联盟范围内实施。
旨在创建协作研究环境、促进数据共享的一系列操作流程
和传播结果,并建设提高癌症研究机构自给自足的能力
坦桑尼亚和赞比亚 3) 提供通信基础设施以吸引主要利益相关者,以促进
联盟,并传播信息和研究成果,为当地的健康政策变化提供信息,
行政核心的组织旨在响应迅速、包容且稳健——
这些属性对于解决 KEAAP 内的广泛使命和复杂关系至关重要,其中
合作机构,以及与 NIH 的合作,其核心将侧重于满足合作者的需求。
快速变化的科学技术进步氛围,以促进可持续的联盟
开展充满活力的研究项目,致力于减少撒哈拉以南非洲地区的癌症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Charles Wood其他文献
Charles Wood的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Charles Wood', 18)}}的其他基金
23rd International Workshop on Kaposi's Sarcoma Herpesvirus (KSHV) and Related Agents
第23届卡波西肉瘤疱疹病毒(KSHV)及相关病原体国际研讨会
- 批准号:
10525451 - 财政年份:2020
- 资助金额:
$ 28.51万 - 项目类别:
23rd International Workshop on Kaposi's Sarcoma Herpesvirus (KSHV) and Related Agents
第23届卡波西肉瘤疱疹病毒(KSHV)及相关病原体国际研讨会
- 批准号:
10754345 - 财政年份:2020
- 资助金额:
$ 28.51万 - 项目类别:
Biomarkers for Dysbiosis-Related HIV-Associated Cognitive Disorders among Persons Who Inject Drugs in Puerto Rico
波多黎各注射吸毒者中与生态失调相关的艾滋病毒相关认知障碍的生物标志物
- 批准号:
10654868 - 财政年份:2019
- 资助金额:
$ 28.51万 - 项目类别:
Biomarkers for Dysbiosis-Related HIV-Associated Cognitive Disorders among Persons Who Inject Drugs in Puerto Rico
波多黎各注射吸毒者中与生态失调相关的艾滋病毒相关认知障碍的生物标志物
- 批准号:
10594192 - 财政年份:2019
- 资助金额:
$ 28.51万 - 项目类别:
Zambia AIDS Malignancies Diagnosis and Pathogenesis Program Supplement
赞比亚艾滋病恶性肿瘤诊断和发病机制计划补充资料
- 批准号:
10533536 - 财政年份:2017
- 资助金额:
$ 28.51万 - 项目类别:
The impact of Cannabis on inflammation and HIV-1 reservoirs in Zambia
大麻对赞比亚炎症和 HIV-1 病毒库的影响
- 批准号:
9920695 - 财政年份:2017
- 资助金额:
$ 28.51万 - 项目类别:
The impact of Cannabis on inflammation and HIV-1 reservoirs in Zambia
大麻对赞比亚炎症和 HIV-1 病毒库的影响
- 批准号:
9529608 - 财政年份:2017
- 资助金额:
$ 28.51万 - 项目类别:
Zambia AIDS Malignancies Diagnosis and Pathogenesis Program Supplement
赞比亚艾滋病恶性肿瘤诊断和发病机制计划补充资料
- 批准号:
10581802 - 财政年份:2017
- 资助金额:
$ 28.51万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Partnership to Assess Viral and Immune Landscape Intersections with ONcology for People Living with HIV (PAVILION)
与肿瘤学合作评估艾滋病病毒感染者的病毒和免疫景观交叉点 (PAVILION)
- 批准号:
10598373 - 财政年份:2023
- 资助金额:
$ 28.51万 - 项目类别:
"Plasma and cellular immune biomarkers of Kaposi's sarcoma in HIV-1 suppressed patients"
“HIV-1 抑制患者中卡波西肉瘤的血浆和细胞免疫生物标志物”
- 批准号:
10871931 - 财政年份:2023
- 资助金额:
$ 28.51万 - 项目类别: